|
|
Article: Arius Lines Up Functional' Antibodies Against Cancer.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
West Coast Editor
"Targeted antibodies, made fast here" may not sound like the sign you'd see hanging outside an office one day, but that - or something like it - is the goal of Arius Research Inc., which reported making progress toward treating cancer patients with more specific drugs.
"It's not autologous," said Helen Findlay, vice president of Toronto-based Arius, about the company's treatment method. "The idea is not that I would take your tumor and give you your antibody only. We're building a large library of antibodies, and when it comes to treating patients, [the process involves] doing an analysis of what antigens they express and then going to ...
Related newspaper, magazine, and journal articles:
|
|
Article: Canadian Inventors Develop Patient Cancerous Disease Modifying ...
US Fed News Service, Including US State News;
February 16, 2007 ;
460 words
... ... Susan E. Hahn and Helen P. Findlay, all from Toronto, have ... cancerous disease modifying antibodies using a novel paradigm of ... segregating the anti-cancer antibodies using cancer cell cytotoxicity ... production of anti-cancer antibodies for therapeutic and diagnostic ...
|
|